Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Drug Discovery Remove
Related Tags


October 2014
Mo Su Sa Fr Th We Tu
20 19 18 17 16 15 14

drug discovery Press Releases

  + XML/RSS  



By SMi Group Ltd
Advances and Progress in Drug Design, 16th & 17th February 2015, Marriott Regents Park Hotel, London UK

By MoBiTec GmbH
In 2009, Phosphodiesterase 4D (PDE4D) was identified as a novel proliferation-promoting factor in prostate cancer. Now, the effects of two selective PDE4D inhibitors, NVP-ABE171 and cilomilast, as anti-prostate cancer therapies were examined.

By SMi Group Ltd
7th annual Advances in Cell Based Assays conference takes place in London, on the 11th - 12th November 2014.

By Cambridge Healthtech Institute
Drug Discovery Teams to Unite for 3 Days of Learning & Collaboration - Free Passes Provide Access to Keynote Presentations by Chas Bountra, Martin Tolar, Andrew Hopkins and an Expansive Exhibit Hall

By Cambridge Healthtech Institute
Novartis, AstraZeneca and Merck to lead an assembly of drug discovery teams in discussing maximizing information in early drug discovery with phenotypic screening

By InvitroCue Pte Ltd
InvitroCue and HD Biosciences Enter Collaboration Agreement for the Validation of Image Analysis Tools for Preclinical Drug Discovery

By Crown Bioscience
HuTrialTM demonstrates commitment to furthering preclinical understanding in order to improve personal care and increase patient recovery rates

By BPS Bioscience, Inc
BPS Bioscience, Inc. (“BPS”) has developed several new assay kits (BTLA:HVEM, CD28:B7-1, and CTLA4:B7-1) and related proteins to advance immunotherapy research.

By Virtue Insight
5th Annual Clinical Trials Summit 2014 "A critical guide for successfully conducting clinical trials” 10th & 11th June 2014, Kohinoor Continental Hotel, Mumbai, India

By Peptides International
Nearly Five Thousand Unique Products Will Be Available Worldwide

By BPS Bioscience, Inc.
BPS Bioscience, Inc. introduces unique EZH2 mutants and 2 new assay kits for screening EZH2 inhibitors

By Cambridge Healthtech Institute
Complimentary passes are available for Bio-IT World Expo, providing access to 5 keynotes, 140+ exhibitors, an annual networking reception and industry awards presentations - all centered around advancing biomedical research and drug development

By Cambridge Healthtech Institute
This event is being held May 22-23, 2014 at the Westin Boston Waterfront, in Boston, Massachusetts

By Cambridge Healthtech Institute
Chas Bountra, Ph.D., Chief Scientist & Head of the Genomics Consortium/University of Oxford, is confirmed to deliver the keynote presentation at CHI’s 14th Annual Structure-Based Drug Design Conference, May 21-22, 2014 in Boston, MA.

By Smartox
Smartox Biotechnology, a start-up company based in France specialized in the study of animal venoms and Sanofi, are pleased to announce a research partnership for the discovery of innovative therapeutic drugs from animal venoms.

By SMi Group
Just 3 weeks remain until SMi open their doors to host the industry established conference on Advances and Progress in Drug Design.

By Cambridge Healthtech Institute
Top scientists from pharma and biotech to deliver new data and case studies for using structure and rational design to accelerate discovery

By Peptides International
A Unique and Useful Application to Drug Discovery Researchers

By The AEgis Technologies Group
ADME WorkBench is a new software tool for pharmacokinetic prediction. The software has several methods for PK prediction and is competitively priced.

By Cambridge Healthtech Institute
The industry’s preeminent event on novel drug targets unites 700+ scientists and technologists for key discussions and connections. The event includes 40+ exhibitors, peer posters and keynote presentations by Stuart Schreiber and Paul Feldman.

All Press Releases

By MoBiTec GmbH
An Application Note is published to serve as a guide for using BellBrook Labs' Transcreener® GDP Assay to detect the activity of guanine nucleotide exchange factors (GEFs) based on their stimulation of steady state GTPase activity.

By SMi Group Ltd
Advances and Progress in Drug Design, 16th & 17th February 2015, Marriott Regents Park Hotel, London UK

By MoBiTec GmbH
In 2009, Phosphodiesterase 4D (PDE4D) was identified as a novel proliferation-promoting factor in prostate cancer. Now, the effects of two selective PDE4D inhibitors, NVP-ABE171 and cilomilast, as anti-prostate cancer therapies were examined.

By SMi Group Ltd
7th annual Advances in Cell Based Assays conference takes place in London, on the 11th - 12th November 2014.

By Cambridge Healthtech Institute
Drug Discovery Teams to Unite for 3 Days of Learning & Collaboration - Free Passes Provide Access to Keynote Presentations by Chas Bountra, Martin Tolar, Andrew Hopkins and an Expansive Exhibit Hall

By Cambridge Healthtech Institute
Novartis, AstraZeneca and Merck to lead an assembly of drug discovery teams in discussing maximizing information in early drug discovery with phenotypic screening

By SMi Group Ltd
SMi Group reports (2014.08.22, London): In preparation for the 5th annual Biosimilars and Biobetters Conference, SMi Group has conducted a series of interviews with leading industry experts

By InvitroCue Pte Ltd
InvitroCue and HD Biosciences Enter Collaboration Agreement for the Validation of Image Analysis Tools for Preclinical Drug Discovery

By VIO Chemicals AG
VIO Chemicals and SpiroChem have obtained a $ 500000 grant from the Swiss government's Commission for Innovation and Technology to merge preparative chemistry and flow technology to develop new processes used in drug discovery and API manufacturing.

By Cures Within Reach
New web portal, built in collaboration with GlobalCures, will accelerate the open medical research approach to discover affordable, effective repurposed therapies

By BPS Bioscience, Inc.
BPS Bioscience, Inc. (BPS) is now offering its newest cell line: the Hippo Pathway TEAD Reporter – MCF7 Cell Line.

By Crown Bioscience
HuTrialTM demonstrates commitment to furthering preclinical understanding in order to improve personal care and increase patient recovery rates

By BPS Bioscience, Inc
BPS Bioscience, Inc. (“BPS”) has developed several new assay kits (BTLA:HVEM, CD28:B7-1, and CTLA4:B7-1) and related proteins to advance immunotherapy research.

By Crown Bioscience
Investment to Fund Rapid Expansion in Translational Platform Technologies for Oncology and Metabolic Diseases

By kdm communications
Field Based Chemistry North America and Europe June 11th, 2014 | Cambridge, MA, USA June 19th - 20th | 2014 Cambridge, UK

By Virtue Insight
5th Annual Clinical Trials Summit 2014 "A critical guide for successfully conducting clinical trials” 10th & 11th June 2014, Kohinoor Continental Hotel, Mumbai, India

By Peptides International
Nearly Five Thousand Unique Products Will Be Available Worldwide

By Crown Bioscience
Size of collection allows for more informed preclinical decision making on prospective drug candidates

By BPS Bioscience, Inc.
BPS Bioscience, Inc. introduces unique EZH2 mutants and 2 new assay kits for screening EZH2 inhibitors

By Cambridge Healthtech Institute
Complimentary passes are available for Bio-IT World Expo, providing access to 5 keynotes, 140+ exhibitors, an annual networking reception and industry awards presentations - all centered around advancing biomedical research and drug development

By Cresset
Cresset, innovative provider of computational chemistry software and services, is pleased to announce the release of our latest set of Pipeline Pilot components V2.0.0.

By Cambridge Healthtech Institute
This event is being held May 22-23, 2014 at the Westin Boston Waterfront, in Boston, Massachusetts

By Cambridge Healthtech Institute
Chas Bountra, Ph.D., Chief Scientist & Head of the Genomics Consortium/University of Oxford, is confirmed to deliver the keynote presentation at CHI’s 14th Annual Structure-Based Drug Design Conference, May 21-22, 2014 in Boston, MA.

By Tecan
Scientists working at the Leibniz-Institute for Molecular Pharmacology (FMP) in Berlin, Germany, are benefitting from the low volume pipetting capability of a MultiChannel Arm™ (MCA) 384 for siRNA and small molecule screening.

By Cresset
Guiding Better Decisions in Drug Discovery and Development March 19th, 2014 at British Embassy in Tokyo March 20th, 2014 at British Consulate-General in Osaka

By Smartox
Smartox Biotechnology, a start-up company based in France specialized in the study of animal venoms and Sanofi, are pleased to announce a research partnership for the discovery of innovative therapeutic drugs from animal venoms.

By SMi Group
Just 3 weeks remain until SMi open their doors to host the industry established conference on Advances and Progress in Drug Design.

By Cambridge Healthtech Institute
Top scientists from pharma and biotech to deliver new data and case studies for using structure and rational design to accelerate discovery

By Peptides International
A Unique and Useful Application to Drug Discovery Researchers

By Allied Market Research
According to a new report titled "Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis,...

By The AEgis Technologies Group
ADME WorkBench is a new software tool for pharmacokinetic prediction. The software has several methods for PK prediction and is competitively priced.

By Cambridge Healthtech Institute
The industry’s preeminent event on novel drug targets unites 700+ scientists and technologists for key discussions and connections. The event includes 40+ exhibitors, peer posters and keynote presentations by Stuart Schreiber and Paul Feldman.

By KDM Communications
A novel solution for analyzing 3D cell cultures, based on Tecan’s Infinite® M200 PRO and InSphero’s 3D InSight™ microtissue technology, is helping to reduce the cost of early phase drug development.

By Cambridge Healthtech Institute
Proven assay development and target identification methods to be presented by GSK, Broad, NIH, University of Pittsburg, iRND3, and more this October in Cambridge, MA

By Cambridge Healthtech Institute
In vitro Models of Tumor Microenvironment for New Cancer Target and Drug Discovery

By Cambridge Healthtech Institute
Headlined by Karen Burg, DL Taylor, Steve Ludbrook and Aaron Morris, CHI's FAST Congress features three days of innovative presentations for more accurate biological response in drug discovery through novel screening technologies and strategies.

By Peptides International
Broad Research Collection of Drug Discovery Tools Released, Includes Exclusive Distribution Agreement

By GDS International
Madrid, SPAIN - June 12, 2013: On 9 – 11 September, C-level executives from across Europe's pharmaceutical industry will convene at the Sheraton Mirasierra Hotel, Madrid at GDS International’s 5th European NG Pharmaceutical Drug Discovery Summit.

By Elsevier
PharmaPendium Metabolizing Enzymes and Transporters Module delivers comprehensive visibility of Drug-Drug-Interactions

By VLI-Research
PHILADELPHIA, PA (April 2013) – The upcoming 2013 Ubiquitin Drug Discovery & Diagnostics Conference, to be held in Philadelphia from July 22th to the 24th, marks the fifth-annual landmark gathering of ubiquitin-focused professionals from academia...

By Cambridge Healthtech Institute
Cambridge Healthtech Institute (CHI) is proud to host its Inaugural FAST: Functional Analysis & Screening Technologies Congress, October 28-30, 2013 in Cambridge, Mass. Speaker proposals will be accepted until April 19, 2013.

By BPS Bioscience, Inc.
Announcing the Availability of Methyl-Lysine Reader Proteins and Assay Kits for a New Class of Epigenetic Drug...

By Biotech Support Group LLC
Biotech Support Group LLC, reports on a new technical poster which describes a new enrichment product PROfessor™, for functional and chemical proteomic...

By Cambridge Healthtech Institute
Drugging the Undruggable: Transforming Nature’s α-Helix into Breakthrough Medicines will be discussed at CHI's 13th Annual Structure-Based Drug Design Conference this coming...

By Cytocentrics Bioscience GmbH
Cytocentrics Bioscience GmbH, inventors of Cytocentering technology for automated patch clamp, is proud to announce the appointment of SciPro Inc.

By Cambridge Healthtech Institute
Bio-IT World has announced that complimentary keynote and exhibit hall passes are now available for the 2013 Bio-IT World Expo, taking place April 9-11 in Boston, MA.

By cardiabase
CardiaBase, a global provider of centralized diagnostic services to clinical trials, is pleased to announce that Dr. Pierre Maison-Blanche joined the company as Chief Medical Officer.

By Biotech Support Group LLC
The patent cites Cleanascite™ from Biotech Support Group in a method for the selection of neutralizing antibodies to mouse IL-17F and IL-17A.

By Cambridge Healthtech Institute
Plenary Keynote Panels on "Personalized Oncology: Fulfilling the Promise for Today’s Patients" and "Emerging Technologies & Industry Perspectives" to be Delivered Next Month in San Francisco

By Cambridge Healthtech Institute
Gain access to solutions and connections for Diagnostics, Informatics, Clinical, Cancer, Therapeutics, Sequencing, Genomics and Medicine and more at Cambridge Healthtech Institute's 20th Annual Molecular Medicine Tri-Conference



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share